Preexisting cardiovascular disease in patients undergoing hematopoietic stem cell transplantation.

Khayata, Mohamed; Al‐Kindi, Sadeer G.; Njoroge, Linda; Lima, Marcos J.G. de; Oliveira, Guilherme H.

doi:10.1200/jco.2018.36.15_suppl.e19501

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study identified 2430 patients who underwent HSCT. Compared to controls, HSCT patients had increased prevalence of hypertension, diabetes, smoking, CAD, peripheral vascular disease, and heart failure at baseline [16]. Moreover, the selection criteria for HSCT are now less restrictive compared to a decade ago, and elderly patients with impaired baseline cardiac function are now considered candidates for HSCT.…”

Section: Introductionmentioning

confidence: 99%

Pretransplant Cardiac Evaluation Using Novel Technology

Hemu

Zimmerman

Okwuosa

2019

JCM

View full text Add to dashboard Cite

Hematopoietic stem-cell transplantation (HSCT) is a complex procedure that has been increasingly successful in treating malignant and nonmalignant conditions. Despite its effectiveness, it can be associated with potentially life-threatening adverse effects. New onset heart failure, ischemic disease, and arrhythmias are among the most notable cardiovascular complications post-HSCT. As a result, appropriate cardiac risk stratification prior to transplant could result in decreased morbidity and mortality by identifying patients with a higher probability of tolerating possible toxicities associated with HSCT. In this review, we aim to discuss the utility of cardiac screening using novel modalities of imaging technology in the pre-HSCT phase.

show abstract

Section: Introductionmentioning

confidence: 99%